Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Gefitinib manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

gefitinib

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, PICS, MHRA, WHO
Manufacturer #38657

The company is a pharmaceutical manufacturer engaged in the development, production and export of a range of pharmaceutical products across key therapeutic segments including oncology, critical care and lifesaving medicines, operating with certified manufacturing capabilities and global distribution networks to supply these pharmaceutical products to international healthcare markets.

Manufacturer usually replies in 27 days

gefitinib

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31073

This pharmaceutical company specializes in oncology and has nearly two decades of experience developing generic and specialty drugs. They focus on delivering affordable, world-class chemotherapy medications across a wide range of therapeutic areas. Their robust research and development team possesses expertise in complex drug molecule development, serving diverse markets globally. With over 35 developed generics and specialty drugs, they have filed over 40 dossiers across 25 countries in emerging markets. The company is committed to expanding its presence in the oncology therapeutic area within emerging markets.

Manufacturer usually replies in 48 days

gefitinib

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply
Manufacturer #10323
This company is a global manufacturer of essential lifesaving medicaments, specializing in high-tech parenteral and oral formulations. Established in 1984, it has grown from a small family business to a multinational corporation with over 2000 employees across 70 markets. Their expertise spans various therapeutic areas including anaesthesiology, critical care, pain management, gynaecology, ophthalmology, orthopaedics, oncology, and dermatology. They offer a diverse product portfolio of over 500 products, including injectables, infusions, and other dosage forms. The company prides itself on its commitment to quality, innovation, ethics, and transparency. They maintain GMP certifications and hold patents for several products. Their manufacturing sites are strategically located across key regions like the EU and North America.

Manufacturer usually replies in 30 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Gefitinib Manufacturers Gefitinib manufacturers sell this Drug under various Brand names like Gefinter, Gefinor, and Iressa. Gefitinib is available in the form of film-coated tablets with the dosage strength of 250mg, which is administered orally once daily and is absorbed slowly with a mean bioavailability of 60%. The dose is the same for both male and female patients irrespective of age and weight. The approved storage conditions for Gefitinib are to be stored at room temperature 20 C – 25 C (68 F- 77 F) under the original package to protect from moisture. Wholesale Price of Gefitinib In the US region, the price of Gefitinib ranges from $6.5 - $8.6 per pill or unit, and the cost can go up to $229 to $604 for the quantity of 60 to 90 tablets, which are available in Aluminum / PVC perforated, or non-perforated blisters. Gefitinib - Mechanism of Action Gefitinib belongs to the Therapeutic class (a group of medicines) of Antineoplastic agents, which is pharmacologically a Tyrosine kinase inhibitor. Tyrosine Kinase is a type of protein that delivers signals telling cancer cells to grow. Gefitinib works by blocking the action of tyrosine kinase by inhibiting these signals thereby preventing the cancer cells from growing and multiplying. Thus, Gefitinib inhibits EGFR tyrosine kinase by binding to the adenosine triphosphate (ATP) binding site of the enzyme with a protein binding capacity of almost 90%. Finding Gefitinib Manufacturers and Suppliers Many times we tend to find manufacturers and suppliers by attending conferences, exhibitions, etc. that is time-consuming and is directly related to money, and we are not sure whether we get the trusted suppliers, which is a major constraint then. One can avoid this constraint by Pipelinepharma, which helps you in finding the trusted manufacturers and suppliers of Gefitinib. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products that quickly connects the owner with the consumer for business development. You can filter the product names in the unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.